InvestorsHub Logo
Followers 3
Posts 289
Boards Moderated 0
Alias Born 12/21/2022

Re: Tartiaboy post# 308

Friday, 03/24/2023 1:21:45 PM

Friday, March 24, 2023 1:21:45 PM

Post# of 569
Yes, unless they want to recruit Ven-naive patients. But if I heard it correctly, they are planing to negotiate a single-arm Tusp/Ven trial for accelerated approval. Therefore, it is absolutely critical what FDA wants to see, ORR and mDoR should be pre-determined.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News